Health IT product news from Rhinogram, Teladoc, HealthPoint Plus, Pearl, Twist Bioscience Corporation, DeliverHealth, Snowflake, Turquoise Health, Sphere, 4medica, DrFirst, HHS Technology Group, Inovalon, and more.
Read More
The health IT industry is driven by growing demand for improved patient safety and patient care as well as increase in government initiatives to promote and adopt health IT. It is estimated to reach $149,178 million by 2025. Here is product news that is making these number real.
The pharmaceutical market plays a key role in how people get medications and what people pay for medication. At the intersection of healthcare, pharma, and technology, here are current news and announcements.
Medical imaging market is expected to gain market growth in the forecast period of 2020 to 2027. In our newest monthly report we are reporting news, innovation, research, and events happening with a focus on medical imaging.
HHS and its agencies share their annual reports and 2020 year in reviews. Like everything in healthcare in 2020, COVID took center stage, but agencies did continue their missions and initiatives.
We’ve rounded up some of the latest news and announcements pertaining to the coronavirus and the healthcare industry.
This is our ongoing reporting on how AI is being integrated into healthcare technology. We are seeking out the thought leaders and innovations that are moving the needle forward which include ANSI, Canon Medical, FDA, Abiomed, IBH Population Health Solutions, Lyssn, Endpoint Health, Genial Technology, & Frost & Sullivan.
By JoNel Aleccia & Anna Maria Barry-Jester – “Save your business while saving lives,” reads the website of Because Health, a Seattle tech startup selling two types of tests to employers willing to pay $350 a pop to learn whether their workers have been infected with COVID-19.
New On Demand Dr. Nick: The Incrementalist: With guest Amy Abernethy, MD, Ph.D. the Principal Deputy Commissioner & Acting CIO for the FDA. We had talked in January at CES about the forthcoming meeting focused on the FDA’s Technology Modernization Action Plan but as a result of the COVID19 pandemic, the meeting was postponed to Jun 30.